Norvis® Tablet: Each film coated tablet contains Tiemonium Methylsulphate INN 50 mg.
Norvis® Injection: Each 2 ml ampoule contains Tiemonium Methylsulphate INN 5 mg.
Norvis® Syrup: Each 5 ml syrup contains Tiemonium Methylsulphate INN 10 mg.
Tiemonium Methylsulphate is a quaternary ammonium antimuscarinic agent with peripheral effect similar to those of atropine. Tiemonium Methylsulphate strengthens calcium bonding with phospholipids and proteins thus stabilizing the cell membrane of the GI tract.
Tiemonium Methylsulphate is an antispasmodic drug. It reduces muscle spasms of the intestine, biliary system, uterus & urinary bladder. It is indicated for the pain in gastrointestinal, biliary, urinary and gynecological disease such as gastroenteritis, diarrhea, dysentery, biliary colic, enterocolitis, cholecystitis, colonopathies, mild cystitis, & spasmodic dysmenorrhoea.
Norvis® Tablet:
Recommended oral dose of Tiemonium Methylsulphate tablet is 2-6 tablets (100-300 mg) daily in divided dose.
Norvis® Injection:
Recommended injectable dose is 1 Tiemonium Methylsulphate Injection 3 times daily, through Intravenous route slowly or Intramuscular route.
Norvis® Syrup:
Children: 3 mg - 6 mg/kg body weight/day or 1.5 ml - 3 ml /kg body weight/day in 3 divided doses.
Adult: 30 mg - 90 mg or 15 ml - 45 ml 3 times daily or as directed by physician.
Tiemonium Methylsulphate should not be used with other drugs without prior consult of a registered physician to avoid possible drug interaction.
Tiemonium Methylsulphate may be used in pregnancy only if it is clearly needed by the assessment of risk benefit ratio.
Tiemonium Methylsulphate may be used in lactating mother only if it is clearly needed by the assessment of risk benefit ratio.